Back to News
Market Impact: 0.45

UK stocks steady as traders await rate cues; sterling holds near lows

BPSHELAZNSNNBCSSBRYDGETRI
Monetary PolicyInterest Rates & YieldsFiscal Policy & BudgetCorporate EarningsCorporate Guidance & OutlookCurrency & FXMarket Technicals & FlowsCompany Fundamentals
UK stocks steady as traders await rate cues; sterling holds near lows

London's FTSE 100 and midcap indexes retreated Thursday, with the FTSE 100 down 0.4% from a record high, as the pound strengthened following the Bank of England's decision to hold interest rates steady. Despite the unchanged rates, a narrow vote and signals from Governor Bailey increased expectations for a December rate cut post-budget. Sectoral performance was mixed, with industrial and aerospace stocks declining, while AstraZeneca gained 3% on strong Q3 results. Notable individual movers included Smith & Nephew plunging 10.8% on missed revenue, Diageo falling 6.5% after trimming forecasts, and Sainsbury rising 5.5% on an upgraded profit outlook.

Analysis

London's main stock indexes, the FTSE 100 and midcap, experienced a pullback on Thursday, with the FTSE 100 closing 0.4% lower from its recent record high, reflecting a broader risk-off sentiment. This occurred despite the Bank of England maintaining interest rates, as the pound strengthened by 0.45% following the decision. The narrow margin in the BoE's vote and Governor Bailey's signals have heightened expectations for a December rate cut, particularly after the upcoming budget announcement. Sectoral performance was notably mixed, with industrial stocks declining 1.8% and aerospace and defence shedding 2.1%, acting as significant market drags. Oil and gas companies like BP and Shell also saw shares fall by 0.5% and 0.4% respectively, influenced by decreasing oil prices. Conversely, the banking index gained 0.8%, with Standard Chartered up 1.5% and Barclays up 1%, reportedly benefiting from expectations of being spared a punitive budget tax. Individual corporate earnings and guidance heavily influenced specific stock movements. AstraZeneca provided support to the pharma sector, gaining 3% on better-than-expected third-quarter profit driven by strong cancer and heart drug sales. In contrast, Smith & Nephew plunged 10.8% after missing quarterly revenue expectations due to weakness in its U.S. knee implants business. Sainsbury's shares rose 5.5% following an upgraded full-year profit outlook, while Diageo fell 6.5% after trimming its 2026 sales and profit forecast.